Rheumatoid Arthritis Flashcards
Pathogenesis
environmental factors + epigentic modification + genes
–> loss of tolerance –> neutrophils in synovial space –> leukocyte and lymphocytes in joint spaces –> cytokines
Inflammation —> synovitis, bone erosion, pannus and cartilage degradation
Systemic inflammation –> heart disease, vascular disease, metabolic syndrome
Risk factor genes for RA
DRB1 = codes for MHC class 2 to bind citrulated peptides
STAT4 = cytokine signalling
PADI = citrallination of peptides
PTPN22 = increased lymphocyte proliferation
Other risk factors
Female Obesity Smoking Periodontitis Gut dysbiosis Viruses - EBV, CMV, parvo, barmah forest, ross river
Anti-CCP
Cells involved in pathogenesis
PMNs - in synovial fluid Macrophages T cells B cells Synovial fibroblasts
Cytokines involved in signalling
Antigen presentation and T cell expansion:
- IFN
- IL-2
- IL-12
- IL-15
- IL-18
- IL-17
Leukocyte trafficking:
- IL-1
- TNF
- IL-8
- MCP
- MIP
Local inflammation and damage: MACROPHAGE PRODUCED
- TNF-Alpha
- IL-1
- IL-6
Pathogenesis of bone erosion
Mediated by osteoclast
Osteoclast generation stimulated by IL-1, IL-6 and TNF
–> RANK-L production –> osteoclast activity
–> destruction of periarticular bone and loss of joint function
Diagnosis of RA
Small joints - Hands not DIPs, wrists, toes, ankles, shoulders
Symmetrical
6weeks of symptoms
Morning stiffness >1hr
Rheumatoid factor or Anti-CCP positive
RA Nodules
Erosions
Other causes of high RF?
RF = antibody directed against the Fc portion of IgG
Sjogrens Syndrome Cyroglobulinaemia SLE Polymyositis Infections Sarcoid IPF PBC
Anti-CCP antibody
Highly specific for RA
Predictive of RA development
Marker of severity of disease
Post translational modification of arginine residues on peptides –> changes to citraline –> immune response to new peptide –> anti-CCP antibody
What are predictors of severity of RA?
EROSIONS
Anti-CCP High CRP at diagnosis High ESR at diagnosis High swollen joint count High disability score Rheumatoid nodules HLA DR4
What factors indicate disease activity?
ESR
CRP
Swollen joint count
Non biologic DMARDs for RA?
Anti-malarials - HCQ
Sulphasalazine
Leflunomide
METHOTREXATE
Why is methotrexate the gold standard treatment?
Effective in 75% of patients
6 weeks to effects
Will have disease flare with discontinuation
Improves QOL and mortality
Side effects:
- Bone marrow suppression
- Abnormal LFTs
- MTX lung
Biologic DMARDs for RA
TNF-Alpha blockers IL-6 blockers CTLA-4 blockers B cell depletion JAK kinase blockers
TNF- Alpha Blockade
TNF-alpha central to the disease process in RA
–> synovitis, bone erosion and joint space narrowing
Drugs:
- Infliximab
- Etanercept
- Adalimumab
Bind both free TNF and bound TNF –> destruction of TNF positive cells
Rapid onset of action
Reduces radiographic progression
Can induce remission if used early
Side effects:
- Infection - TB and HBV, bacterial, VZV, HSV
- Lymphoma and skin cancer
- Demylination
- CCF
- Drug induced lupus